Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Woebot Health Names Matt Borowiecki Chief Financial Officer
Woebot Health, a mental health ally for people and businesses, today announced that it has […]
Gamida Cell Appoints Terry Coelho as CFO
Gamida Cell, a cell therapy pioneer working to turn cells into powerful therapeutics, has announced […]
Coeptis Therapeutics Appoints Brian Cogley as Chief Financial Officer
Coeptis Therapeutics, a biopharmaceutical company developing innovative cell therapy platforms for cancer, announced today the […]
SynAct Pharma Appoints Björn Westberg as Chief Financial Officer (CFO)
SynAct Pharma has announced that Björn Westberg has been appointed Chief Financial Officer (CFO) and […]
Capstan Therapeutics Appoints Justin Thacker as Chief Financial Officer and Jeffrey Pepe, J.D., Ph.D., as General Counsel
Capstan Therapeutics, a biotechnology company dedicated to advancing in vivo reprogramming of cells through targeted […]
Ankyra Therapeutics Appoints Experienced Financial Executive Stephen Gorgol as Chief Financial Officer
Ankyra Therapeutics, a biotech company developing targeted immune-activating agents for the treatment of cancer, has […]
Harbinger Health Appoints Vincent Lozada as Chief Financial Officer
Harbinger Health, a biotechnology company pioneering the detection of early cancer, announced today the appointment […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more